{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:51:57Z","timestamp":1760622717281},"reference-count":19,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1995,3,1]]},"DOI":"10.1136\/thx.50.3.223","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T03:22:59Z","timestamp":1229138579000},"page":"223-224","source":"Crossref","is-referenced-by-count":2,"title":["New and future antibiotics in the treatment of acute respiratory tract infections."],"prefix":"10.1136","volume":"50","author":[{"given":"R","family":"Wise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"1604","article-title":"Steingrimsson 0. Increasing penicillin resistance in pneumococci in Iceland","volume":"339","author":"Kristinsson, K.G.; Hjalmarsdottir, M.A.","year":"1992","unstructured":"Kristinsson KG, Hjalmarsdottir MA, Steingrimsson 0. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992;339:1604-7.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/clinids\/14.2.427","article-title":"Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study","volume":"14","author":"Garcia-Leoni, M.E.; Cercenado, E.; Rodeno, P.; de Quiros JCLB Hernandez; DM, Bouza; E.","year":"1992","unstructured":"Garcia-Leoni ME, Cercenado E, Rodeno P, de Quiros JCLB Hernandez DM, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992;14: 427-35.","journal-title":"Clin Infect Dis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archinte.1986.00360170064009","article-title":"Bacteriology of hospital acquired pneumonia","volume":"146","author":"Bartlett, J.G.; O'Keefe, P.; Tally, F.P.; Louie, T.J.; Gorbach, S.L.","year":"1986","unstructured":"Bartlett JG, O'Keefe P, Tally FP, Louie TJ, Gorbach SL. Bacteriology of hospital acquired pneumonia. Arch Intern Med 1986;146:868-71.","journal-title":"Arch Intern Med"},{"key":"ref_4","first-page":"195","article-title":"British Thoracic Society and Public Health Laboratory Service. Community acquired pneumonia in adults in British Hospitals 1982-83; a survey of aetiology, mortality, prognostic factors and outcome","volume":"62","year":"1987","unstructured":"British Thoracic Society and Public Health Laboratory Service. Community acquired pneumonia in adults in British Hospitals 1982-83; a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987;62: 195-220.","journal-title":"Q J Med"},{"key":"ref_5","first-page":"58","article-title":"A comparison of intravenous ciprofloxacin dosage regimens in severe nosocomial infections","volume":"B):","author":"Kljucar, S.; Heimesaat, M.; Ev, Pritzbuer; Timm, J.; Bauernfeind, A.","year":"1992","unstructured":"Kljucar S, Heimesaat M, Pritzbuer Ev, Timm J, Bauernfeind A. A comparison of intravenous ciprofloxacin dosage regimens in severe nosocomial infections. Infect Med 1992;9(Suppl B):58-72.","journal-title":"Infect Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/33.1.103","article-title":"The comparative pharmacokinetics and tissue penetration of single dose ciprofloxacin 400 mg i.v. and 750mg p.o","volume":"33","author":"Catchpole, C.; Andrews, J.M.; Woodcock, J.; Wise, R.","year":"1994","unstructured":"Catchpole C, Andrews JM, Woodcock J, Wise R. The comparative pharmacokinetics and tissue penetration of single dose ciprofloxacin 400 mg i.v. and 750mg p.o. JAntimicrob Chemother 1994;33:103-10.","journal-title":"JAntimicrob Chemother"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jac\/26.5.667","article-title":"In vitro activity of sparfloxacin, a new quinolone antimicrobial agent","volume":"26","author":"Cooper, M.A.; Andrews, J.M.; Ashby, J.P.; Matthews, R.S.; Wise, R.","year":"1990","unstructured":"Cooper MA, Andrews JM, Ashby JP, Matthews RS, Wise R. In vitro activity of sparfloxacin, a new quinolone antimicrobial agent. JAntimicrob Chemother 1990;26:667-76.","journal-title":"JAntimicrob Chemother"},{"key":"ref_8","first-page":"65","article-title":"Comparative pharmacokinetic disposition of fluoroquinolones in the lung","volume":"C):","author":"Wise, R.; Baldwin, D.R.; Andrews, J.M.; Honeyboume, D.","year":"1991","unstructured":"Wise R, Baldwin DR, Andrews JM, Honeyboume D. Comparative pharmacokinetic disposition of fluoroquinolones in the lung. Jf Antimicrob Chemother 1991;28(Suppl C):65-71.","journal-title":"Jf Antimicrob Chemother"},{"key":"ref_9","article-title":"Treatment of suspected pneumococcal community-acquired pneumonia (CAP): a comparison of sparfloxacin and amoxycillin. 33rdIntersci ConfAntimicrobAgent Chemother","volume-title":"Abstract 1024","author":"Aubier, M.; Geslin, P.; C, Regamey; Vester, R.","year":"1993","unstructured":"Aubier M, Geslin P, Regamey C and Vester R. Treatment of suspected pneumococcal community-acquired pneumonia (CAP): a comparison of sparfloxacin and amoxycillin. 33rdIntersci ConfAntimicrobAgent Chemother, New Orleans, 1993, Abstract 1024."},{"key":"ref_10","first-page":"757","article-title":"The in vitro activity of a new highly active quinolone, DU 6859a. J7 Antimicrob","volume":"32","author":"Jolly, A.; Andrews, J.M.; Brenwald, N.; Wise, R.","year":"1993","unstructured":"Jolly A, Andrews JM, Brenwald N, Wise R. The in vitro activity of a new highly active quinolone, DU 6859a. J7 Antimicrob Chemother 1993;32: 757-63.","journal-title":"Chemother"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/AAC.37.2.366","article-title":"In vitro activity of CP 99219, a new fluoroquinolone, against clinical isolates of Gram positive bacteria","volume":"37","author":"Elipoulas, G.M.; Klimm, K.; Elipoulos, C.T.; Ferraro, M.J.; Moellering, R.C.","year":"1993","unstructured":"Elipoulas GM, Klimm K, Elipoulos CT, Ferraro MJ, Moellering RC. In vitro activity of CP 99219, a new fluoroquinolone, against clinical isolates of Gram positive bacteria. Antimicrob Agents Chemother 1993;37:366-70.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/AAC.32.8.1251","article-title":"In vitro activity of PD127,391 an enhanced spectrum quinolone","volume":"32","author":"Wise, R.; AshbyJP, Andrews; J.M.","year":"1988","unstructured":"Wise R, AshbyJP, Andrews JM. In vitro activity of PD127,391 an enhanced spectrum quinolone. Antimicrob Agents Chemother 1988;32:1251-6.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_13","first-page":"497","article-title":"The in vitro activity of OPC 17116, a new 5-methylsubstituted quinolone. J7 Antimicrob","volume":"31","author":"Wise, R.; Andrews, J.M.; Brenwald, N.","year":"1993","unstructured":"Wise R, Andrews JM, Brenwald N. The in vitro activity of OPC 17116, a new 5-methylsubstituted quinolone. J7 Antimicrob Chemother 1993;31: 497-504.","journal-title":"Chemother"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1183\/09031936.93.03080886","article-title":"Azithromycin concentrations at the sites of pulmonary infection","volume":"3","author":"Baldwin, D.R.; Wise, R.; AndrewsJM, AshbyJP; Honeyboume, D.","year":"1990","unstructured":"Baldwin DR, Wise R, AndrewsJM, AshbyJP, Honeyboume D. Azithromycin concentrations at the sites of pulmonary infection. Eur Respir Jf 1990;3: 886-90.","journal-title":"Eur Respir Jf"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.94.07071275","article-title":"The levels of clarithromycin and its 14-hydroxy metabolite in the lung","volume":"7","author":"Honeybourne, D.; Kees, F.; Andrews, J.M.; Baldwin, D.; Wise, R.","year":"1994","unstructured":"Honeybourne D, Kees F, Andrews JM, Baldwin D, Wise R. The levels of clarithromycin and its 14-hydroxy metabolite in the lung. Eur Respir Jf 1994;7:1275-80.","journal-title":"Eur Respir Jf"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen, N.R.; Manfreda, J.; Carren, C.P.W.; Gershfeld, E.S.; Harding, G.K.M.; Nelson, N.A.","year":"1987","unstructured":"Anthonisen NR, Manfreda J, Carren CPW, Gershfeld ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-203.","journal-title":"Ann Intern Med"},{"key":"ref_17","first-page":"507","article-title":"Randomised placebocontrolled trials of antibiotics for acute bronchitis","volume":"36","author":"Orr, P.H.; Scherer, K.; Macdonald, A.; Moffatt, M.E.K.","year":"1993","unstructured":"Orr PH, Scherer K, Macdonald A, Moffatt MEK. Randomised placebocontrolled trials of antibiotics for acute bronchitis. J Fam Pract 1993;36: 507-12.","journal-title":"J Fam Pract"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/AAC.37.11.2270","article-title":"In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semi-synthetic tetracyclines","volume":"37","author":"Testa, R.T.; Peterson, P.J.; Jacobus, N.V.; Sum, P.E.; Lee, V.J.; Tally, F.P.","year":"1993","unstructured":"Testa RT, Peterson PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semi-synthetic tetracyclines. AntimicrobAgents Chemother 1993;37:2270-7.","journal-title":"AntimicrobAgents Chemother"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/AAC.38.5.1096","article-title":"In vitro activity of two glycylcyclines","volume":"38","author":"Wise, R.; Andrews, J.M.","year":"1994","unstructured":"Wise R, Andrews JM. In vitro activity of two glycylcyclines. Antimicrob Agents Chemother 1994;38:1096-102.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.50.3.223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T22:45:58Z","timestamp":1684795558000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thx.50.3.223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3,1]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.50.3.223","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3,1]]}}}